Multivalent Melanotropic Peptide and Fluorescent Macromolecular Conjugates: New Reagents for Characterization of Melanotropin Receptors

Bioconjugate Chemistry

Volumn 5, Issue 6, 1994, Pages 591-601

  Sharma, Shubh D ^a   Hruby, Victor J ^a   Granberry, Michael E ^a   Leong, Stanley P L ^a   Jiang, Jinwen ^a   Hadley, Mac E ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROMOLECULAR CONJUGATES;

ANIMALIA;

EID: 0028535271     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc00030a015     Document Type: Article

References (49)

1. Hadley, M. E. (1992) Endocrinology, 3rd ed., Prentice-Hall, Inc., Englewood Cliffs, NJ.
2. Hadley, M. E. (1988) The Melanotropic Peptides, Vol. I: Source, Synthesis, Chemistry, Secretion, and Metabolism (M. E. Hadley, Ed.) CRC Press, Boca Raton, FL.
3. Lerner, A. B.; McGuire, J. S. (1961) Effect of alpha and beta melanocyte stimulating hormones on the skin colour of man. Nature, 185, 176–179.
4. Lerner, A. B.; McGuire, J. S. (1964) Melanocytestimulating hormone and adrenocorticotrophic hormone: Their relation to pigmentation. N. Engl. J. Med., 270, 539–546.
5. Levine, N.; Sheftel, S. N.; Eytan, T.; Dorr, R. T.; Hadley, M. E.; Weinrach, J. C.; Ertl, G. A.; Toth, K.; McGee, D. L.; Hruby, V. J. (1991) Induction of skin tanning by the subcutaneous administration of a potent synthetic melanotropin. J. Am. Med. Assoc., 266, 2730–2736.
6. 2 with the F1 variant of B16 melanoma cells. J. Cellular Physiol. 132, 97–103.
7. Siegrist, W.; Solca, F.; Stutz, S.; Giuffre, L.; Carrel, S.; Girard, J.; Eberle, A. N. (1989) Characterization of receptors for α-melanocyte stimulating hormone on human melanoma cells. Cancer Res., 49, 6352–6358.
8. Siegrist, W.; Ostreicher, M.; Stutz, S.; Girard, J.; Eberle, A. (1988) Radioreceptor assay for α-MSH using mouse B16 melanoma cells. J. Receptor Res., 8, 323–343.
9. Solca, F.; Siegrist, W.; Drozdz, R.; Girard, J.; Eberle, A. N. (1989) The receptor for alpha-melanotropin of mouse and human melanoma cells: application of a potent photoaffinity label. J. Biol. Chem., 264, 14277–14281.
10. 7]α-MSH in B16/F10 mouse melanoma cells. (Private communication).
11. Tatro, J. B.; Watson, M. L.; Lester, B. R.; Reichlin, S. (1990) Melanotropin receptors of murine melanoma characterized in cultured cells and demonstrated in experimental tumors in situ. Cancer Res., 50, 1237–1242.
12. Tatro, J. B.; Reichlin, S. (1987) Specific receptors for α-melanocyte-stimulating hormone are widely distributed in tissues of rodents. Endocrinology, 121, 1900–1907.
13. Libert, A.; Ghanem, G.; Arnould, R.; Lejeune, F. (1989) Use of an alpha-melanocyte-stimulating hormone analogue to improve alpha-melanocyte stimulating hormone receptor binding assay in human melanoma. Pigment Cell Res., 2, 510–518.
14. Legros, F.; Coel, J.; Doyen, A.; Hanson, P.; Van Tieghem, N.; Vercammen-Grandjean, A.; Fruhling, J.; Lejeune, F. J. (1980) α-Melanocyte-stimulating hormone binding and biological activity in a human melanoma cell line. Cancer Res., 41, 1539–1544.
15. Ghanem, G. E.; Communale, A.; Libert, A.; Vercammen-Granjean, A.; Lejeune, F. (1988) Evidence for alpha-melanocyte-stimulating hormone (α-MSH) receptors on human malignant melanoma cells. Int. J. Cancer, 41, 248–255.
16. Tatro, J. B.; Atkins, M.; Mier, J. W.; Hardarson, S.; Wolfe, H.; Smith, T.; Entwistle, M. L.; Reichlin, S. (1990) Melanotropin receptors demonstrated in situ in human melanoma. J. Clin. Invest., 85, 1825–1832.
17. 7]α-melanocyte stimulating hormone: a highly potent α-melanotropin with ultralong biological activity. Proc. Natl. Acad. Sci. U.S.A. 77, 5754–5758.
18. 7]α-MSH: a superpotent melanotropin that “irreversibly” activates melanoma tyrosinase. Endocr. Res. 11, 157–170.
19. 7]α-MSH-substituted α-melanotropins. Cancer Res. 45, 4735–4740.
20. Hruby, V. J.; Sharma, S. D.; Toth, K.; Jaw, J. W.; Al-Obeidi, F.; Sawyer, T. K.; Hadley, M. E. (1993) Design, synthesis, and conformation of superpotent and prolonged acting melanotropins. Ann. N.Y. Acad. Sci., 680, 51–63.
21. Sharma, S. D.; Hruby, V. J.; Hadley, M. E.; Granberry, M. E.; Leong, S. P. (1992) Multivalent ligands for diagnosis and therapeutics. In Peptides: Chemistry and Biology, Proceedings of the Twelfth American Peptide Symposium (J. A. Smith and J. E. Rivier, Eds.) pp 599–600, ESCOM, Leiden, The Netherlands.
22. Zeiller, K.; Pascher, G.; Hannig, K. (1972) Preparative electrophoretic separation of antibody forming cells. Prepar. Biochem., 2, 21–37.
23. Hruby, V. J.; Wilkes, B. C.; Hadley, M. E.; Al-Obeidi, F.; Sawyer, T. K.; Staples, D. J.; deVaux, A. E.; Dym, O.; Castrucci, A. M. L.; Hintz, M. F.; Riehm, J. R.; Rao, R. (1987) Alpha-Melanotropin: The minimum active sequence in the frog skin bioassay. J. Med. Chem., 30, 2126–2130.
24. Kaiser, E.; Colescott, R. L.; Bossinger, C. D.; Cook, P. I. (1970) Color test for detection of free terminal amino groups in the solid phase synthesis of peptides. Anal. Biochem., 34, 595–598.
25. Christensen, T. (1979) A chloranil color test for monitoring coupling completeness in solid phase peptide synthesis. In Peptides, Structure and Biological Function (E. Gross and J. Meienhofer, Eds.) pp 385–388, Pierce Chemical Co., Rockford, IL.
26. Haugland, R. P. (1991) Fluorescent labels. In Biosensors with Fiberoptics (D. L. Wise and L. B. Wingard, Eds.) pp 85–109, Humana Press.
27. Kitagawa, T.; Aikawa, T. (1976) Enzyme coupled immunoassay of insulin using a novel coupling reagent. J. Biochem., 79, 233–236.
28. Silverstein, R. M.; Bassler, G. C.; Morrill, T. C. (1981) Spectrometric Identification of Organic Compounds, 4th ed., p 322, John Wiley and Sons, New York.
29. Carlsson, J.; Drevin, H.; Axen, R. (1978) Protein thiolation and reversible protein-protein conjugation: N-succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. Biochem. J. 173, 723–737.
30. Stuchbury, T.; Shipton, M.; Norris, R.; Malthouse, J. P. G.; Brocklehurst, K.; Herbert, J. A. L.; Suschitzky, H. (1975) A reporter group delivery system with absolute and selective specificity for thiol groups and an improved fluorescent probe containing the 7-nitrobenzo-2-oxa-1,3 diazole moiety. Biochem. J., 151, 417–432.
31. Schwyzer R.; Kriwaczek, V. M. (1981) Tobacco mosiac virus as a carrier for small molecules: Artificial receptor antibodies and superhormones. Biopolymers, 20, 2011–2020.
32. Wunderlin, R.; Sharma, S. D.; Minakakis, P.; Schwyzer, R. (1985) Melanotropin receptors II. Synthesis and biological activity of α-melanotropin/tobacco mosiac virus disulfide conjugates. Helv. Chim. Acta, 68, 12–22.
33. Greenbury, C. L.; Moore, D. H.; Nunn, L. A. C. (1965) The reaction with red cells of 7S rabbit antibody, its subunits and their recombinants. Immunology, 8, 420–431.
34. Schwyzer, R.; Kriwaczek, V. M.; Wunderlin, R. (1981) A method for mapping peptide receptors. Naturwissenschaften, 68, 95–96.
35. White, J. G.; Escolar, G. (1990) Induction of receptor clustering, patching, and capping on surface-activated platelets. Lab. Invest., 63, 332–340.
36. Keller, G. A.; Siegel, M. W.; Caras, I. W. (1992) Endocytosis of glycophospholipid-anchored and transmembrane forms of CD4 by different endocytic pathways. EMBO J., 11, 863–874.
37. Weintraub, W. H.; Negulescu, P. A.; Machen, T. E. (1992) Calcium signaling in endothelia: Cellular heterogeneity and receptor internalization. Am. J. Physiol., 263C, 1029–1039.
38. Jarett, L.; Smith, R. M. (1974) Electron microscopic demonstration of insulin receptors on adipocyte plasma membranes utilizing a ferritin-insulin conjugate. J. Biol. Chem., 249, 7024–7031.
39. dePriester, W.; Bakker, A.; Lamers, G. (1990) Capping of Con A receptors and actin distribution are influenced by disruption of microtubules in. Distyostelium discoideum. Eur. J. Cell Biol., 51, 23–32.
40. Orci, L.; Rufener, C.; Malaisse-Lagae, F.; Blondel, B.; Amherdt, M.; Bataille, D.; Freylet, P.; Perrelet, A. (1975) A morphological approach to surface receptors in islet and liver cells. Isr. J. Med. Sci., 11, 639–655.
41. Varga, J. B.; Dipasquale, A.; Pawelek, J.; McGuire, J. S.; Lemer, A. B. (1974) Regulation of melanocyte stimulating hormone action at the receptor level: Discontinuous binding of hormone to synchronized mouse melanoma cell cycle. Proc. Natl. Acad. Sci. U.S.A., 71, 1590–1593.
42. Lerner, A. B.; Moellmann, G.; Varga, J. M.; Halaban, R.; Pawelek, J. (1979) Action of melanocyte-stimulating hormone on pigment cells. In Cold Spring Harbor Conference on Cell Proliferation (G. H. Soto, A. B. Pardee, and D. A. Sirbascu, Eds.) Vol. 6, pp 187–197, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
43. Orlow, S. J.; Hotchkiss, S.; Pawelek, J. M. (1990) Internal binding sites for MSH: analyses in wild-type and variant Cloudman melanoma cells. J. Cell. Physiol., 142, 129–136.
44. McLane, J. A.; Pawelek, J. M. (1988) Receptors for β-melanocyte-stimulating hormone exhibit positive cooper-ativity in synchronized melanoma cells. Biochem., 27, 3743–3747.
45. Fuller, B. B.; Brooks, B. A. (1980) Application of percent labeled mitoses (PLM) analysis to the investigation of melanoma cell responsiveness to MSH stimulation throughout the cell cycle. Exp. Cell Res., 126, 183–190.
46. Shimizu, N.; Shimizu, Y.; Fuller, B. B. (1981) Cell-cycle analysis of insulin binding and internalization on mouse melanoma cells. J. Cell Biol., 88, 241–244.
47. Wong, G.; Pawelek, J.; Sansone, M.; Morowitz, J. (1974) Response of mouse melanoma cells to melanocyte stimulating hormone. Nature, 248, 351–354.
48. Pawelek, J. (1976) Factors regulating growth and pigmentation of melanoma cells. J. Invest. Dermatol., 66, 201–209.
49. Bard, D. R.; Knight, C. G.; Page-Thomas, D. P. (1990) Targeting of a chelating derivative of a short-chain analog of α-melanocyte stimulating hormone to Cloudman S91 melanomas. Biochem. Soc. Trans., 18, 882–883.